|
|
Article: Commercial Insight: Insomnia Strong Brand Identity Critical To Differentiation In An Increasingly Crowded Market.
- Article from:
- Business Wire
- Article date:
- July 13, 2007
CopyrightCOPYRIGHT 2007 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c62690) has announced the addition of "Commercial Insight: Insomnia Strong Brand Identity Critical to Differentiation in an Increasingly Crowded Market" to their offering.
Ambien has remained the clear leader in the insomnia market for over a decade, with 2006 sales of over $2.3 billion across the seven major markets. The success of Ambien is attributable to a favorable side-effect profile and half-life. However, due to recent patent expiries in the US and Japan, Ambiens leadership status is finally under threat and the market is undergoing some dramatic changes
Scope of ...